Stocks
Amylyx Pharmaceuticals (AMLX) EBITDA margin US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | -938.2% | -5 957% | -29 013% | -905.7% | 10.5% | -20.1% | |
| Changes by years, y/y, % | -5 019pp | -23 056pp | +28 108pp | +916pp | ||||
Amylyx Pharmaceuticals. EBITDA margin, %
Amylyx Pharmaceuticals. EBITDA margin, changes, pp
Amylyx Pharmaceuticals (AMLX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -2.87% | 20.9% | 18.5% | 2.06% | -137.4% | -20.1% | |
| Changes by years, y/y, % | +15 820pp | +206pp | -135pp | |||||
| Changes by quarters, q/q, % | +201pp | +24pp | -2pp | -16pp | -139pp | |||
